Ind-Swift Labs. vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Ind-Swift Labs. currently has the stronger revenue growth signal.
Ind-Swift Labs. show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Ind-Swift Labs. | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹385 | ₹1,840 |
| Market Cap | ₹3,351.06 Cr. | ₹4.41 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 51.49 | 34.95 |
| ROE (%) | 3.87 | 15.95 |
| Debt/Equity | 0.01 | 0.06 |
| Sales Growth 5Y (%) | -6.37 | 11.78 |
| Profit Growth 5Y (%) | 164.17 | 2.54 |
| Promoter Holding (%) | 42.93 | 54.48 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | No information |
| Fundraise | No information | No information |